Take a trial of UK to unlock this pageFind out more
© Stockopedia 26th February, 2017


GSK 1639.5p 7.0  0.4%
24/02/17 1.50k

« All RNS

GLAXOSMITHKLINE | Transaction In Own Shares | RNS

RNS Number : 5996X
GlaxoSmithKline PLC
16 February 2012

GlaxoSmithKline plc (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 5 May 2011 it purchased 420,000 of its Ordinary shares of 25 pence each ("shares") on 16 February 2012.


The highest price paid per share was 1,426.5 pence per share.

The lowest price paid per share was 1,404.0 pence per share.

The Company intends to hold these shares in Treasury.


The Company holds 502,862,927 of its shares in Treasury, representing 9.05% of the total issued share capital of the Company. 


Including shares which have been purchased but not yet settled, the Company holds 504,192,927 of its shares in Treasury, representing 9.98% of the total voting rights in the Company.


The Company has 5,050,618,069 shares in issue (excluding shares held in Treasury). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.


This announcement does not constitute, or form part of, an offer or any solicitation of an offer to purchase or subscribe for securities in any jurisdiction and is in conformity with the Financial Services Authority's Disclosure and Transparency Rules.

This information is provided by RNS
The company news service from the London Stock Exchange

GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company's segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals business develops and makes medicines to treat a range of acute and chronic diseases. The Vaccines business develops, produces and distributes over 1.9 million vaccines every day to people across the world. The Consumer Healthcare business develops and markets products in various categories, such as Wellness, Oral health, Nutrition and Skin health. The Pharmaceuticals Research and Development (R&D) focuses on the discovery and development in various areas of research, which include human immunodeficiency virus (HIV) and infectious diseases, oncology, immuno-inflammation, respiratory and rare diseases. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis